Publication & Citation Trends
Publications
0 total
Genetic modifiers of APOE-ε4-associated cognitive decline
Cited by 0
Semantic Scholar
Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer’s disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
Cited by 0
Semantic Scholar
Target product profiles for treatments to delay or prevent symptomatic Alzheimer’s disease
Cited by 0
Semantic Scholar
Human lifespan changes in the brain’s functional connectome
Cited by 74
Semantic Scholar
Relationships of PGRN with sTREM2 in AD continuum and non-AD pathophysiology and their reciprocal roles in modulating amyloid pathology: two population-based study
Cited by 3
Semantic Scholar
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial.
Cited by 15
Semantic Scholar
Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies known and novel cross-population and ancestry-specific associations as novel risk loci for Alzheimer’s disease
Cited by 7
Semantic Scholar
Research Topics
Dementia and Cognitive Impairment Research
(227)
Alzheimer's disease research and treatments
(183)
Health Systems, Economic Evaluations, Quality of Life
(75)
Functional Brain Connectivity Studies
(45)
Cholinesterase and Neurodegenerative Diseases
(45)
Affiliations
Boston University
Roche (Switzerland)
University of North Texas
Roche (United States)
National Institutes of Health